SavedAdd your journal

Journals / Journal of Surgery and Medicine / 2021 / Cilt: 5 - Sayı: 4

A prospective study on the relationship between COVID-19 disease progress and cardiovascular damage

Bedri Caner KAYA
Yusuf ÇEKİCİ
Berna KAYA
Ahmet CELİK
Hüseyin Avni DEMİR
Nurdan YILMAZ
Pages
322–326
Publication Date
2021-04-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The mean ages of patients treated in the ICU unit and the ward were 69.5 (57.5-80.5) years and 40 (29-58) years, respectively (P

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aim: Covid-19 is a new coronavirus disease with high mortality that has reached all parts of the world.
📊
Key Findings & Data:This study aimed to prospectively compare individual characteristics, echocardiographic findings, and laboratory findings in patients with Covid-19 according to the need for intensive care unit (ICU) admission and mortality.
💡
Conclusion & Impact:The mean ages of patients treated in the ICU unit and the ward were 69.5 (57.5-80.5) years and 40 (29-58) years, respectively (P
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:covid-19 · d-dimer · cardiac damage

Abstract

Background/Aim: Covid-19 is a new coronavirus disease with high mortality that has reached all parts of the world. This study aimed to prospectively compare individual characteristics, echocardiographic findings, and laboratory findings in patients with Covid-19 according to the need for intensive care unit (ICU) admission and mortality. Methods: In this single-center prospective cohort study, patients hospitalized with the diagnosis of Covid-19 between June and November 2020 were examined in terms of echocardiographic and laboratory results. Early in-hospital findings that might affect mortality, cardiac injury and thrombotic complications were evaluated and compared. Results: A total of 214 patients who were hospitalized due to Covid-19 were included in our study, 80 (37.3%) of which needed hospitalization in the ICU and 134 (62.6%) of which did not. The mean ages of patients treated in the ICU unit and the ward were 69.5 (57.5-80.5) years and 40 (29-58) years, respectively (P

🔖

Cite This Article

KAYA, B. C., ÇEKİCİ, Y., KAYA, B., CELİK, A., DEMİR, H. A., YILMAZ, N. (2021). A prospective study on the relationship between COVID-19 disease progress and cardiovascular damage. Journal of Surgery and Medicine, Cilt: 5 - Sayı: 4, 322–326. https://ajindex.com/articles/779969

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Nik Muhamad NA, Hawari R, Shafie H. A case report of aluminium phosphide poisoning. Med J Malaysia. 2016;71:213-4
  2. Zhu H, Rhee JW, Cheng P, Waliany S, Chang A, Witteles RM, et al. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response. Curr Cardiol Rep. 2020;22:32
  3. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533-4
  4. Zhang S, Diao M, Yu W, Pei L, Lin Z, Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis. Int J Infect Dis. 2020;93:201-4
  5. Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020;31:1003-8
  6. Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. J Card Surg. 2020;35:1302-5
  7. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802-10
  8. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846-8
  9. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5:811-8
  10. Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2021;42(2):206
  11. Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical characteristics of 2019 novel coronavirus infection in China. Med Rxiv. 2020. doi:10.1101/2020.02.06.20020974 12. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020;17:259-60
  12. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061-9
  13. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020;63:390-1
  14. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk facto